Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
The Journal of Infectious Diseases2008Vol. 198(2), pp. 226–233
Citations Over TimeTop 10% of 2008 papers
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy J. Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, Robert T. Chen
Abstract
Influenza vaccines contain structures that can induce anti-GM(1) antibodies after inoculation into mice. Further research into influenza vaccine components that elicit anti-ganglioside responses and the role played by these antibodies (if any) in vaccine-associated GBS is warranted.
Related Papers
- → Role of Infection Due to Campylobacter jejuni in the Initiation of Guillain-Barre Syndrome(1993)157 cited
- → Does Campylobacter jejuni infection elicit “demyelinating” Guillain–Barre syndrome?(2005)9 cited
- → Does Campylobacter jejuni infection elicit axonal or demyelinating Guillain-Barre syndrome, or both?(2011)10 cited
- → ROLE OF INFECTION DUE TO CAMPYLOBACTER JEJUNI IN THE INITIATION OF GUILLAIN-BARRE SYNDROME(1994)4 cited
- CAMPYLOBACTER JEJUNI INFECTION IN PATIENTS WITH KOREAN GUILLAIN-BARRE SYNDROME(2013)